NCT02734290: Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 29 taking part
- Started
- 23 Feb 2016
- Primary completion
- 21 Aug 2019
- Arms
- Arm B
- Results
- Posted on the registry
- 23 Feb 2016: Trial started
- 12 Apr 2016: Trial registered
- 22 Feb 2024: Trial results posted